This study examines the remarkable effectiveness of Withaferin-A (WA), a withanolide obtained from Withania somnifera (Ashwagandha), in encountering the mortiferous breast malignancy, a global peril. The predominant objective is to investigate WA’s intrinsic target proteins and hedgehog (Hh) pathway proteins in breast cancer targeting through the application of in silico computational techniques and network pharmacology predictions. The databases and webtools like Swiss target prediction, GeneCards, DisGeNet and Online Mendelian Inheritance in Man were exploited to identify the common target proteins. The culmination of the WA network and protein–protein interaction network were devised using Stitch and String web tools, through which the drug–target network of 30 common proteins was constructed employing Cytoscape-version 3.9. Enrichment analysis was performed by incorporating Gprofiler, Metascape and Cytoscape plugins. David compounded the Gene Ontology and Kyoto Encyclopedia of Genes and Genomes, and enrichment was computed through bioinformatics tools. The 20 pivotal proteins were docked harnessing Glide, Schrodinger Suite 2023-2. The investigation was governed by docking scores and affinity. The shared target proteins underscored the precise Hh and WA network roles with the affirmation enrichment P-value of <0.025. The implications for hedgehog and cancer pathways were profound with enrichment (P < 0.01). Further, the ADMET and drug-likeness assessments assisted the claim. Robust interactions were noticed with docking studies, authenticated through molecular dynamics, molecular mechanics generalized born surface area scores and bonds. The computational investigation emphasized WA’s credible anti-breast activity, specifically with Hh proteins, implying stem-cell-level checkpoint restraints. Rigorous testament is imperative through in vitro and in vivo studies.
Globally, 2.3 million women were diagnosed with breast cancer, with 6,85000 mortalities in year 2021; making it the world's most prevalent cancer. This growing global burden necessitates a new treatment option, and plant-based medicines offers a promising alternative to conventional cancer treatment. In this work, screening of phytoconstituents of an indigenous therapeutic plant, Bauhinia variegata carried out for potential regulator of tumor suppressor protein p53. Here, an in-silico analysis was employed to develop more effective, pharmaceutically potent small drug-like compounds that target tumor suppressor protein p53. The methanol and aqueous powdered extracts of Bauhinia variegata were prepared and phytochemically evaluated along with antioxidant property evaluation. The LC50 of methanol (325.33 µg/ml) and aqueous extract (361.15 µg/ml) showed their cytotoxic characteristics. Further, GCMS analysis of both the extracts reveals total 57 secondary metabolites. Among these, four lead compounds; compound 1, compound 2, compound 3 and compound 4 were found to have the highest binding ability (-8.15 to -5.40 kcal/mol) with p53. MD simulation and binding free energy validates these findings with highest binding free energy (-67.09 ± 4.87 kcal/mol) towards p53 by the lead phytocompound 2. Selected compounds exhibit excellent pharmacokinetic features and drug-like characteristics. The acute toxicity (LD50) values of the lead phytocompounds ranges from 670 mg/kg to 3100 mg/kg, with toxicity classes of IV and V. As a result, these druggable phytochemicals could serve as potential lead applicants for triple negative breast cancer treatment. However, more in vitro and in vivo research is planned to produce future breast cancer medicine. HIGHLIGHTSScreening of phytoconstituents of an indigenous therapeutic plant, Bauhinia variegata, for potential regulator of tumor suppressor protein p53.The LC50 of methanol (325.33µg/ml) and aqueous extract (361.15µg/ml) showed their cytotoxic characteristics.GCMS analysis of both the extracts reveals total 57 secondary metabolites. Among these, four lead compounds were found to have the highest binding affinity (-8.153 to -5.401 kcal/mol) with tumor suppressor protein p53.MD simulation along with the Prime MM/GBSA binding free energy validates this discovery with highest binding free energy (-67.09 ± 4.87 kcal/mol) towards p53 by the lead compound 2.The acute toxicity (LD50) values of the lead phytocompounds ranges from 670 mg/kg to 3100 mg/kg, with toxicity classes of IV and V.As a result, these druggable phytochemicals could serve as potential lead applicants for triple negative breast cancer treatment.Communicated by Ramaswamy H. Sarma.
29 September 2022 in Biomedical and Pharmacology Journal
The classification of drugs varies from country to country, with active foods, dietary supplements and traditional medicines being included in certain categories. The stability of those products is also unknown and complex to the critical problem in the analysis of herbal products that this is a complex ingredient combination, as well as the elements responsible for the treatment effects. In order to identify the changes to the newly introduced regulations or regulations, detailed literary searches and online searches for herbal medicinal products regulations have been made in South-east Asia and European countries. Curcumin is an important pharmaceutical compound derived from turmeric. Curcumin is extracted from dried curcuma longa rhizomes. The demand for curcumin grows daily due to its use in the treatment of a number of diseases. Curcumin has long established challenges with its health benefits, such as poor uptake and poor bioavailability.
1 January 2020 in Research Journal of Pharmacy and Technology
Exogenous or external antioxidants are required in the form of a food supplements and/or medicines to protect the body from oxidative stress and ultimately from heart disease, stroke, aging and other risks specially cancer. A liquid polyherbal preparation was developed as Saptarangi Plus Kadha which contains three medicinally important herbs such as Salacia chinensis, Curcuma longa and Tinospora cordifolia. The antioxidant activity of Saptarangi Plus Kadha and individual extracts of the said three herbs were carried out by antioxidant capacity assays such DPPH (1, 1-diphenyl-2-picrylhydrazyl radical), FRAP (Ferric reducing antioxidant power) and H2O2 scavenging. The absorbance was measured on UV spectrophotometer at required wavelengths and IC50 values were calculated for Saptarangi Plus Kadha and individual extracts. The individual herbs in combination showed a good synergistic antioxidant activity in SK. Hence, the results are superior for Saptarangi Plus Kadha over individual extracts of the said three herbs. Thus the results of the study proved that Saptarangi Plus Kadha has synergistic antioxidant potential than individual extracts of the said three herbs which indicates further exploration of research work.